Google has announced a partnership with the Institute of Women’s Cancers, with the aim to find ways in which AI tools can help “improve outcomes” for female patients with breast cancer and gynaecological cancers.
Formed at the France AI Action Summit, the partnership aims to develop an understanding of how AI can “help better address cancer” with research focusing on the role of AI tools when predicting the progression of cancer and any potential risks of relapse. Other areas of focus include utilising their combined expertise for the “identification of new biomarkers that can predict which patients will benefit from specific therapies” and exploring the “origins of tumours, their evolution over time and the specific characteristics of rarer and more complex cancers”.
To help support this, Google is reportedly investing more than $2 million in funding to French research university, Université PSL to “accelerate applied AI scientific research”, as well as offering AI skills training for staff at the Institute of Women’s Cancers and research and treatment centre, Institut Curie.
Speaking on this new partnership, Anne Vincent-Salomon, director of the Institute of Women’s Cancers commented: “Combining our expertise in research with Google’s advanced technological capabilities offers hope for significant advancements in our mission to improve our understanding and prediction of cancer’s progression, and develop more effective treatments.”
Earlier this month, Google revealed the latest 16 companies selected for its 2025 Google for Startups Growth Academy: AI for Cybersecurity program. Each company is said to receive training from Google to help them learn how to appropriately scale their AI-powered solutions. The academy is to take place in Warsaw over a one-year period, starting on 26 March, with Google providing “personalised workshops and mentoring sessions” which will reportedly include insights from AI and cybersecurity experts. Learn more about the 16 companies benefiting from this project.
AI in healthcare: the wider trend
One of our most recent polls indicated that the majority of healthcare professionals (41 percent) see support for safe adoption as the main barrier to responsible AI. Inadequate regulation received 25 percent of the vote, with lack of evidence and evaluation receiving 22 percent and data and data bias receiving 13 percent.
The University Hospitals of Leicester NHS Trust and University Hospitals of Northamptonshire NHS Trust Group recently joined a European network for responsible AI, where members focus on improving the quality, safety, and trustworthiness of AI in healthcare.
Our latest HTN Now webinar, supported by Restore Information Management, focused on the practicalities of AI technologies, including implementation, adoption, the role of data and best practices. We also took a closer look at examples of AI in health and care and how to deal with risk and regulation around AI implementation.
Stay informed about AI and data in healthcare with all the latest news from HTN, including expert interviews and insightful panel discussions.
